GlassScriptPhysician profile
Aadil M Patel
NPI 1982055018
$3,869.87
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $842 · 2020: $1,519 · 2021: $1,311 · 2022: $198.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $2,976.47 | 2019-2021 | |
| Paragon 28, INC. | $159.73 | 2020-2022 | |
| Smith+Nephew, INC. | $147.72 | 2019-2020 | |
| Arteriocyte Medical Systems, INC. | $103.24 | 2019 | |
| Biopro, INC. | $100.68 | 2021 | |
| Stryker Corporation | $98.01 | 2019-2020 | |
| Osteomed LLC | $84.21 | 2019 | |
| Organogenesis INC. | $71.89 | 2022 | |
| Depuy Synthes Sales INC. | $63.75 | 2020 | |
| Acera Surgical, INC. | $22.30 | 2019 | |
| Wright Medical Technology, INC. | $16.16 | 2020 | |
| Horizon Therapeutics Plc | $12.95 | 2019 | |
| Integra Lifesciences Corporation | $12.76 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aadil Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.